Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14889782 | 1.00 | FPR2 (0.53) | FPR2ANPEP | |
| SCHEMBL14889713 | 0.96 | FPR2 (0.49) | FPR2ANPEP | |
| SCHEMBL14889781 | 0.90 | FPR2 (0.56) | FPR2ANPEP | |
| SCHEMBL22150345 | 0.90 | FPR2 (0.54) | FPR2ANPEP | |
| SCHEMBL14890002 | 0.90 | FPR2 (0.54) | FPR2ANPEP | |
| SCHEMBL14889808 | 0.90 | FPR2 (0.56) | FPR2ANPEP | |
| SCHEMBL20983182 | 0.90 | FPR2 (0.56) | FPR2ANPEP | |
| SCHEMBL14889714 | 0.88 | FPR2 (0.58) | FPR2ANPEP | |
| SCHEMBL14902807 | 0.88 | FPR2 (0.58) | FPR2ANPEP | |
| SCHEMBL22175152 | 0.87 | FPR2 (0.51) | FPR2ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104114164-B | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor-like-1 (FPRL-1) receptor modulators | 阿勒根公司 | 2016-11-16 | — | — | CN | claimed |
| EP-3795148-B1 | USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES | ALLERGAN INC (US) | 2025-06-18 | — | — | EP | disclosed |
| EP-3795148-A1 | USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES | ALLERGAN, INC. (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-2964213-B1 | USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR INFLAMMATORY DISEASES | ALLERGAN INC (US) | 2020-11-04 | — | — | EP | disclosed |